öλÔÓéÀֵǼÈë¿ÚÏÂÔØ

µ¼Ê¦ÐÕÃû£ºÂ½äÞ
ÐÔ±ð£ºÅ®
ÈËÆøÖ¸Êý£º902

ËùÊôԺУ£ºÄþ²¨´óѧ
ËùÊôԺϵ£ºÒ½Ñ§Ôº
Ö°³Æ£º½ÌÊÚ
µ¼Ê¦ÀàÐÍ£º
ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÄÚ¿Æѧ
Ñо¿ÁìÓò£º ѪҺÄÚ¿Æ
Ñо¿ÁìÓò£º ѪҺÄÚ¿Æ [ÊÕÆð]




ͨѶ·½Ê½ :
°ì¹«µç»°£º**
µç×ÓÓʼþ£º**@qq.com
ͨѶµØÖ·£ºÄþ²¨ÊаÙÕɶ«Â·251ºÅ


¸öÈ˼òÊö :
½äÞ£¬Å®£¬Ò½Ñ§Ë¶Ê¿¡£ÏÖÈÎÄþ²¨´óѧҽѧԺ¸½ÊôÛ´ÖÝҽԺסԺҽʦ¹æ·¶»¯Åàѵ»ùµØÖ÷ÈΣ¬ÑªÒºÖÐÐij£Îñ¸±Ö÷ÈΣ¬ÑªÒº¿ÆÖ÷ÈΣ¬Ö÷ÈÎҽʦ¡£

öλÔÓéÀֵǼÈë¿ÚÏÂÔØ·½ÏòÊdzÉÈËѪҺ¶ñÐÔÖ×ÁöµÄÁÙ´²ÓëʵÑéÑо¿¡£Ä¿Ç°¹²Ö¸µ¼Ë¶Ê¿Ñо¿Éú9Ãû¡£2008-2009ÄêÔÚÃÀ¹ú CITY OF HOPE ¹ú¼ÒҽѧÖÐÐÄѪҺ²¡Àí²¿·ÃÎÊѧϰ1Äê¡£20ÓàÄêÀ´Ò»Ö±´ÓÊÂѪҺ²¡ÁÙ´²¼°¿ÆÑй¤×÷,ÔÚ¼±ÐÔËèϵ°×Ѫ²¡·Ö×ÓÉúÎïѧµÄÁÙ´²ÊµÑéÑо¿·½ÃæÈ¡µÃÒ»¶¨µÄ³É¹û¡£ÒÔµÚÒ»×÷Õß»òͨѶ×÷ÕßÉí·Ý·¢±íöλÔÓéÀֵǼÈë¿ÚÏÂÔØÂÛÎÄ50Óàƪ£¬ÆäÖÐSCIÂÛÎÄ11ƪ£¬ÖлªÀàÂÛÎÄ20Óàƪ¡£½üÄêÀ´Ö÷³Ö²ÎÓë½ü10ÏîÊ¡Êм¶¿ÎÌ⣬¿ÆÑгɹû»ñÕã½­Ê¡Ò½Ò©ÎÀÉú¿Æ¼¼½ø²½¶þµÈ½±2ÏÈýµÈ½±2ÏÄþ²¨ÊпƼ¼½ø²½½±3Ï»ñÊ¡ÊÐ×ÔÈ»¿ÆѧÓÅÐãÂÛÎĶþµÈ½±4Ïî¡£±»ÆÀΪÄþ²¨Êеڶþ½ìÓÅÐãÖÐÇàÄêÎÀ¼¼È˲Å¡¢2012ÄêÄþ²¨ÊпƼ¼Áì¾ü°Î¼âÈ˲ţ¨µÚ¶þ²ã´Î£©¡¢2015ÄêÄþ²¨ÊпƼ¼Áì¾ü°Î¼âÈ˲ţ¨µÚÒ»²ã´Î£©¡¢2016ÄêÛ´ÖÝÇøÓÅÐãÈ˲Å¡£


¿ÆÑй¤×÷ :
·¢±íöλÔÓéÀֵǼÈë¿ÚÏÂÔØÂÛÎÄ50¶àƪ£¬SCIÂÛÎÄ11ƪ£¬Öлª¼¶¿¯Îï10Óàƪ

1. Meta-analysis of the actions of antithymocyte globulin in patients undergoing allogeneic hematopoietic cell transplantation. Oncotarget, 2017,IF 5.008

2.ALK-negative Anaplastic Large Cell Lymphoma with Extensive Peripheral Blood and Bone Marrow Involvements Manifested as ¡°Leukemic Phase¡±. Leukemia Research£¬2010£¬ IF 2.23

3. C/Ebpa Gene Mutation and C/Ebpa Promoter Hypermethylation in Acute Myeloid Leukemia with Normal Cytogenetics. American Journal of Hematology£¬2010£¬IF 3.57

4.A rapid, lethal blastoid transformation of B-cell chronic lymphocytic leukemia carrying ATM/11q deletion and trisomy 12.

Leukemia Research£¬2009£¬IF 2.23

5.Primary Myelofibrosis Relapsed with Duodenal Myeloid Sarcoma after Allogeneic Stem Cell Transplant .Leukemia Lymphoma£¬ 2009£¬ IF 1.93

6.Musashi2»ùÒòÔÚ³ÉÈ˳õ·¢¼±ÐÔËèϵ°×Ѫ²¡Öеıí´ï¼°ÁÙ´²ÒâÒ壬¡¶ÖлªÒ½Ñ§ÒÅ´«Ñ§ÔÓÖ¾¡·2014ÄêµÚ6ÆÚ

7.41ÀýÂýÐÔÁ£µ¥ºËϸ°û°×Ѫ²¡»¼ÕßȾɫÌåºËÐÍÌØÕ÷·ÖÎö£¬¡¶ÖлªÒ½Ñ§ÒÅ´«Ñ§ÔÓÖ¾¡·2013ÄêµÚ2ÆÚ

8.CDX2»ùÒòÔÚ³õ·¢AMLÖеıí´ï¼°ÁÙ´²ÒâÒ壬¡¶ÖлªÑªÒºÑ§ÔÓÖ¾¡·2012ÄêµÚ10ÆÚ

9.Ò»ÖÖ¿ìËÙ¡¢¼ò±ãµÄͬʱ¼ì²âÕý³£ºËÐͼ±ÐÔËèϵ°×Ѫ²¡FLT3-ITDºÍNPM1»ùÒòÍ»±ä·½·¨µÄ½¨Á¢£¬¡¶ÖлªÒ½Ñ§ÒÅ´«Ñ§ÔÓÖ¾¡· 2012ÄêµÚ2ÆÚ

10.ID1»ùÒòÔÚ¼±ÐÔËèϵ°×Ѫ²¡Öбí´ï¼°ÁÙ´²ÒâÒåµÄÑо¿.¡¶ÖлªÑªÒºÑ§ÔÓÖ¾¡· 2012ÄêµÚ2ÆÚ
Õã½­Ê¡Ö×Áöѧ»áίԱ£¬Õ㽭ʡѪҺѧ»áίԱ£¬Õã½­Ê¡ÄÚ¿Æѧ»áίԱ£¬Äþ²¨Ò½Ñ§»áѪҺѧ·Ö»áÃØÊé¡£

½ü5ÄêÖ÷³Ö¿ÎÌâ

1.2017ÄêÕã½­Ê¡Ò½Ò©ÎÀÉú¿ÎÌ⣺¸ÄÁ¼CLAG·½°¸Ðò¹áµ¥±¶ÌåÔìѪ¸Éϸ°ûÒÆÖ²ÖÎÁƸßΣ¸´·¢¼±ÐÔËèϵ°×Ѫ²¡

2.2016ÄêÛ´ÖÝÇø¿ÎÌ⣺¸ÄÁ¼CLAG·½°¸Ðò¹áÒì»ùÒòÔìѪ¸Éϸ°ûÒÆÖ²ÖÎÁƸßΣÄÑÖÎÐÔ¼±ÐÔËèϵ°×Ѫ²¡

3.2014ÄêÄþ²¨ÊÐ×ÔÈ»¿Æѧ»ù½ð£ºBrd4 ÒÖÖƼÁJQ1ÁªºÏ¸ßÈý¼âɼõ¥¼î£¨HHT£©¶Ô¼±ÐÔËèϵ°×Ѫ²¡£¨AML£©×÷Óü°»úÖÆÑо¿

4.2014ÄêÄþ²¨ÊÐÉç·¢¹¥¹ØÏîÄ¿£º¸ßÈý¼âɼõ¥¼îÁªºÏATRA¼°ATOÖÎÁƸßΣ¼±ÐÔÔçÓ×Á£Ï¸°û°×Ѫ²¡ÁÙ´²Ñо¿
¿ÆÑгɹû»ñÕã½­Ê¡Ò½Ò©ÎÀÉú¿Æ¼¼½ø²½¶þµÈ½±2ÏÈýµÈ½±2ÏÄþ²¨ÊпƼ¼½ø²½½±3Ï»ñÊ¡ÊÐ×ÔÈ»¿ÆѧÓÅÐãÂÛÎĶþµÈ½±4Ïî¡£±»ÆÀΪÄþ²¨Êеڶþ½ìÓÅÐãÖÐÇàÄêÎÀ¼¼È˲Å¡¢2012ÄêÄþ²¨ÊпƼ¼Áì¾ü°Î¼âÈ˲ţ¨µÚ¶þ²ã´Î£©¡¢2015ÄêÄþ²¨ÊпƼ¼Áì¾ü°Î¼âÈ˲ţ¨µÚÒ»²ã´Î£©¡¢2016ÄêÛ´ÖÝÇøÓÅÐãÈ˲Å¡£